Mel Hayes
2023
In 2023, Mel Hayes earned a total compensation of $2.2M as Executive Vice President, Patient Affairs at Fulcrum Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $160,300 |
---|---|
Option Awards | $1,561,354 |
Salary | $471,200 |
Total | $2,192,854 |
Hayes received $1.6M in option awards, accounting for 71% of the total pay in 2023.
Hayes also received $160.3K in non-equity incentive plan and $471.2K in salary.
Rankings
In 2023, Mel Hayes' compensation ranked 461st out of 2,790 executives tracked by ExecPay. In other words, Hayes earned more than 83.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 461 | 84th |
Manufacturing | 265 | 83rd |
Chemicals And Allied Products | 184 | 79th |
Drugs | 181 | 78th |
Pharmaceutical Preparations | 112 | 81st |
Hayes' colleagues
We found five more compensation records of executives who worked with Mel Hayes at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Bryan Stuart
Fulcrum Therapeutics
Chief Executive Officer
2023
Robert Gould
Fulcrum Therapeutics